4th Biennial World Summit of Brain Tumour Patient Advocates
October 9-12, 2019
Bethesda, MD, USA
Representative: Irina Odnoletkova, Ph.D., MBA, VP Health Technology Assessment
Festival of Biologics
October 15-17, 2019
Basel, Switzerland
Representatives:
Katharina Billian-Frey, Ph.D., Senior Scientist Drug Discovery/Protein Engineering
Oliver Hill, Ph.D., VP Drug Discovery/Lead Optimization
Presentation on October 16, 12:05 pm:
"HERA-CD40L: A unique hexavalent CD40 agonist for cancer immunotherapy"
ISPOR Europe 2019
November 2-6, 2019
Copenhagen, Denmark
Representative: Irina Odnoletkova, Ph.D., MBA, VP Health Technology Assessment
Poster Presentation on November 4, 3:30-7:00 pm (Poster Author Discussion Hour: 6:00-7:00 pm):
"Therapeutic Benefit of Orphan Drugs in Oncology: Evidence at the Point of European Marketing Authorisation"
BIO-Europe 2019
November 11-13, 2019
Hamburg, Germany
Representatives:
Juergen Gamer, Ph.D., VP Business Development
Niclas Kneisel, Ph.D., Alliance Manager
11th Annual PEGS Europe
November 18-22, 2019
Lisbon, Portugal
Representatives:
Katharina Billian-Frey, Ph.D., Senior Scientist Drug Discovery/Protein Engineering
Oliver Hill, Ph.D., VP Drug Discovery/Lead Optimization
Presentation by Dr. Hill on November 22, 2:35 pm:
"HERA-GITRL: A Unique Hexavalent GITR Agonist for Cancer Immunotherapy"
SNO 2019 Annual Meeting
November 22-24, 2019
Phoenix, AZ, USA
Representative: Juergen Gamer, Ph.D., VP Business Development
8th Annual PREDiCT: Tumour Models London Summit
December 4-6, 2019
London, UK
Representative: Mauricio Redondo-Müller, Ph.D., Director Preclinical Development
19th Annual PepTalk
January 20-24, 2020
San Diego, CA, USA
Representative: Katharina Billian-Frey, Ph.D., Senior Scientist Drug Discovery/Protein Engineering
AACR Annual Meeting 2020
April 24-29, 2020
San Diego, CA, USA
Representatives:
Christian Gieffers, Ph.D., VP Protein Chemistry
Christian Merz, Ph.D., Head of Cellular Analytics
Meinolf Thiemann, Ph.D., Director Protein Analytics